A clinical trial shows the neuroprotective effect of lixisenatide, a GLP-1 receptor agonist. Its use during a year prevented patients from getting worse, in what has been described as limited but promising benefits
Genetic adaptations have impacted the blood compositions of two populations from Papua New Guinea, finds study phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.